To view the PDF file, sign up for a MySharenet subscription.

PSG GROUP LIMITED - Reviewed results for the year ended 28 February 2014

Release Date: 16/04/2014 14:16
Code(s): PSG PGFP     PDF:  
Wrap Text
Reviewed results for the year ended 28 February 2014

PSG Group Limited
Incorporated in the Republic of South Africa
Registration number: 1970/008484/06
JSE Ltd (“JSE”) share code: PSG
ISIN number: ZAE000013017
(“PSG Group” or “PSG” or “the company” or “the group”)

PSG Financial Services Limited
Incorporated in the Republic of South Africa
Registration number: 1919/000478/06
JSE share code: PGFP
ISIN number: ZAE000096079
(“PSG Financial Services”)

REVIEWED RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2014

•  Sum-of-the-parts value per share increased by 31% year-on-year
•  Recurring headline earnings increased by 14% to 446,9 cents per share
•  Dividend for the year increased by 20% to 133 cents per share
•  Sum-of-the-parts value of R106,42 per share as at 11 April 2014

COMMENTARY 

OUR BUSINESS

PSG is an investment holding company consisting of underlying investments that operate across a diverse range of industries
including financial services, banking, private equity, agriculture and education. PSG’s market capitalisation (net of
treasury shares) is approximately R18,6bn, with its largest investment a 28,3% interest in Capitec.

OUR OBJECTIVE

Our objective remains to continuously create wealth for all shareholders through share price appreciation and the payment of 
dividends.

STRATEGY ­ PROJECT INTERNAL FOCUS

In April last year, PSG introduced its latest strategy, Project Internal Focus, to the market. PSG’s investment portfolio 
contains a healthy balance between established and start-up businesses, all of which offer attractive growth potential. The 
majority of PSG’s most significant successes has been businesses that were either started by, or in conjunction with, PSG. 
Capitec, PSG Konsult and Zeder are all examples of same. In order to extract maximum value, we formalised Project Internal 
Focus, a strategy whereby our focus is primarily directed at the optimisation, refinement and growth of PSG’s existing 
investment portfolio.

Capitec is a good example of an established business that requires limited attention from PSG management. It has achieved 
much success to date with exponential growth in headline earnings per share since establishment in 2001. Capitec continues to 
provide PSG with a solid earnings base to leverage. Investments in the development phase on the other hand, such as Curro and 
Chayton, require more active strategic input from PSG. These companies are likely to experience new business strain while 
expanding, and are anticipated to only start making a meaningful contribution to PSG’s earnings in later years. This has a 
negative impact on PSG’s earnings and dividend growth in the short to medium term as the cost of funding associated with the
investment exceeds the investment yield achieved from an earnings and cash flow perspective.

Project Internal Focus in action

The drive to revisit and, if necessary, reformulate the business strategy of each investment throughout the group, is showing 
promise. Every underlying business has now compiled a revised strategic plan for the next few years, and the appointed
successor CEOs at some of our larger investments have already made a positive contribution towards the future success of
those businesses.

PERFORMANCE

We believe that performance should be measured on the return that an investor receives over time, with a specific focus on per 
share wealth creation.

When evaluating PSG’s performance over the long term, one should focus on the total return index (“TRI”) as measurement tool. 
The TRI is the compound annual growth rate (“CAGR”) of an investment, and is calculated by taking cognisance of share price 
appreciation, dividend and other distributions. This is a sound measure of wealth creation and a reliable method to benchmark 
different companies. PSG’s TRI as at 28 February 2014 was 50,1% per annum, measured over the 18-year period since PSG's
establishment in November 1995. We are proud of this achievement.

When evaluating PSG’s performance over the short to medium term, we focus on the growth in PSG’s sum-of-the-parts (“SOTP”) 
value per share and recurring headline earnings per share. History confirms that PSG’s share price tracks its SOTP value per 
share. Positive growth in PSG’s SOTP value per share thus inevitably results in share price appreciation. However, an increase 
in PSG’s SOTP value per share over time will ultimately depend on sustained growth in the profitability of its underlying 
investments. PSG consequently introduced the recurring headline earnings per share concept to provide management and 
investors with a more realistic and transparent way of evaluating PSG’s performance from an earnings perspective.

RESULTS

PSG had a satisfactory year to 28 February 2014, both from a growth in SOTP value and recurring headline earnings per share 
perspective.

SOTP

The calculation of the SOTP value is simple and requires limited subjectivity as 83% of the value is calculated using listed 
and over-the-counter traded share prices, while other investments are included at market-related valuations. At 28 February 
2014, the SOTP value per PSG share was R95,01 (2013: R72,67) ­ a 27% CAGR over the last three years. At 11 April 2014, the 
SOTP value was R106,42 per share.

                                                     28 Feb     29 Feb       28 Feb       28 Feb
                                                       2011       2012         2013         2014         % of
Asset/Liability                                          Rm         Rm           Rm           Rm        total

Capitec*                                              5 138      5 978        6 128        5 989           30
Curro*                                                           1 118        2 607        4 660           23
PSG Konsult**                                         1 206      1 483        2 237        4 004           20
Zeder*                                                1 069      1 067        1 412        1 698            8
PSG Private Equity***                                 1 242        728          681          949            5
Thembeka Capital***                                                570          899        1 243            6
PSG Corporate (including PSG Capital)****               350        338          383          383            2
Other investments (including cash)****                  548        684        1 505        1 122            6
Total assets                                          9 553     11 966       15 852       20 048          100
Perpetual pref funding*                              (1 028)    (1 188)      (1 163)      (1 393)
Other debt****                                         (507)      (463)        (845)        (615)
Total SOTP value                                      8 018     10 315       13 844       18 040
 
Shares in issue (net of treasury shares) (m)          171,3      184,5        190,5        189,9

SOTP value per share (rand)                           46,81      55,92        72,67        95,01

Net asset value per share (rand)                      21,56      26,50        32,62        37,48

* Listed on the JSE Ltd  ** Over-the-counter  *** SOTP value  **** Valuation

Capitec remains PSG’s largest investment and represented 30% (2013: 39%) of the SOTP value’s total assets as at 28 February 
2014. Its share price has virtually remained unchanged over the past three years following continuous negative publicity 
regarding the unsecured lending market and despite strong earnings growth. Its price earnings (“PE”) ratio has as a result 
decreased from 21x to 11x over this period. Curro and PSG Konsult now respectively represent 23% (2013: 16%) and 20% (2013: 14%)
of PSG’s total assets following an increase in share price and the aforementioned Capitec PE-rerating. However, Capitec 
continues to be the major contributor to PSG’s recurring headline earnings.

RECURRING HEADLINE EARNINGS
                                               
                                                     29 Feb                  28 Feb                      28 Feb
                                                       2012     Change         2013       Change          2014
                                                         Rm          %           Rm            %            Rm

Capitec                                               362,4         38        499,9           14         570,7
Curro                                                  (5,2)       n/a          8,1          154          20,6
PSG Konsult                                           107,9         10        118,8           37         162,7
Zeder                                                 115,4         (8)       106,6           17         124,5
PSG Private Equity                                     32,0        134         75,0          (31)         51,4
Thembeka Capital                                       18,7         50         28,0          (17)         23,2
PSG Corporate (including PSG Capital)                  20,4        (22)        15,9          (56)          7,0
Other                                                  19,3         60         30,8           26          38,9
Recurring headline earnings before funding            670,9         32        883,1           13         999,0
Funding                                              (134,4)        25       (168,2)           8        (181,2)
Recurring headline earnings                           536,5         33        714,9           14         817,8
Non-recurring items                                    30,6        423        160,1           19         191,0
Headline earnings                                     567,1         54        875,0           15       1 008,8
Non-headline items                                    135,9         95        264,8          (84)         43,2
Attributable earnings                                 703,0         62      1 139,8           (8)      1 052,0

Weighted average number of shares in issue (net of
treasury shares) (m)                                  173,9                   182,2                      183,0

Earnings per share (cents)
­ Recurring headline                                  308,6         27        392,3           14         446,9
­ Headline                                            326,2         47        480,2           15         551,3
­ Attributable/basic                                  404,4         55        625,5           (8)        574,9

Dividend per share (cents)                             82,0         35        111,0           20         133,0

Recurring headline earnings for the year ended 28 February 2014 increased by 14% to 446,9 cents per share, following 
exceptional earnings growth from PSG Konsult together with strong growth from Capitec and Zeder.

Headline earnings increased by 15% to 551,3 cents per share. Headline earnings included non-recurring gains of R191m 
(2013: R160m), resulting in headline earnings per share being 23% higher than recurring headline earnings per share. 
The non-recurring headline gains mainly consisted of marked-to-market profits achieved on PSG’s interest rate hedge and 
Thembeka’s portfolio of listed shares, as well as a performance fee earned from PSG’s management of Zeder.

Attributable earnings decreased by 8% to 574,9 cents per share mainly as a result of the non-headline profits achieved on 
the disposal of PSG’s Capitec rights offer shares and Zeder’s disposal of a 15,1% interest in Capevin Holdings in the prior 
year.

CAPITEC (28,3%)

Capitec continued to deliver attractive results amidst challenging conditions in the unsecured credit market with a 15% 
increase in headline earnings per share for the year ended 28 February 2014. It continues to become less dependent on lending 
income with a 43% increase in net transaction fee income, which now covers 59% (2013: 45%) of operating expenses.

In our opinion, Capitec is an exceptional business managed by talented people. The company is well capitalised with a 39% 
capital adequacy ratio, has further tightened its credit criteria and maintains a conservative provisioning policy. PSG remains 
excited about this investment.

Capitec’s comprehensive results for the year ended 28 February 2014 are available at www.capitecbank.co.za.

CURRO (57,1%)

Curro continues to assert its leading position in the South African private school market, albeit a small percentage of same.

It currently operates 31 (2013: 26) campuses accommodating 27 263 (2013: 20 840) learners from three months to grade 12, and 
continues to make private schooling more accessible to South Africans offering fees that range between R1 000 and R6 500 per 
month.

Curro reported an 80% increase in revenue and an 87% increase in headline earnings per share for its financial year ended 
31 December 2013. It is well underway to achieve its target of 80 campuses by 2020 and plans to develop 10 new campuses in the 
year ahead.

Curro will undertake a R589m rights issue, underwritten by PSG, to help fund its capital expansion during the year ahead.

Curro’s comprehensive results for the year ended 31 December 2013 are available at www.curro.co.za.

PSG KONSULT (64,7%)

PSG Konsult recently reported its first set of full year financial results under its refocused business model and Francois 
Gouws’s leadership as new CEO. PSG Konsult’s recurring headline earnings per share increased by 34% for the year ended 
28 February 2014. Each of the three divisions, namely Wealth, Asset Management and Insure, produced commendable results.

PSG Wealth has maintained its upward revenue trend benefiting from positive client inflows, increased trading activity and 
favourable market conditions. PSG Asset Management is a high growth area and increased brand awareness has facilitated strong 
client inflows from both retail and institutional investors. PSG Insure has shown subdued revenue growth amidst a fiercely 
competitive market, particularly on the personal lines business. However, inward reinsurance income has shown significant growth.

Funds under management increased by 38% to R112bn, while funds under administration increased by 31% to R235bn during the year 
under review.

PSG Konsult’s strategic focus for the year ahead is top line revenue growth, which will enable it to unlock operational leverage 
scale benefits now that it has successfully bedded down its repositioning.

PSG Konsult intends listing on the JSE during June 2014.

PSG Konsult’s comprehensive results for the year ended 28 February 2014 are available at www.psg.co.za.

ZEDER (42,4%)

Zeder is an investor in the broad agribusiness industry with a specific focus on the food and beverage sectors. The value of its 
underlying investment portfolio amounted to R4,9bn as at 28 February 2014. Agri Voedsel (with its 30,4% interest in Pioneer 
Foods) remains a large strategic investment representing 39,8% of the portfolio. During the year under review, Zeder continued 
rebalancing its portfolio in line with its amended strategy. It disposed of investments valued at R529m and invested R879m 
primarily to acquire additional stakes in its existing core portfolio (including Agri Voedsel, Capespan, Chayton, Kaap Agri and 
Zaad).

Zeder reported a 26% increase in its SOTP value per share and a 16% increase in recurring headline earnings per share for the 
year ended 28 February 2014, with all its core portfolio investments contributing positively.

Zeder’s comprehensive results for the year ended 28 February 2014 are available at www.zeder.co.za.

PSG PRIVATE EQUITY (100%)

PSG Private Equity’s portfolio contains a range of businesses across various industries and in different stages of maturity. 
The portfolio delivered weaker than expected results for the year ended 28 February 2014 with a 31% decrease in recurring
headline earnings. However, management remains optimistic about the earnings growth potential of this investment portfolio.

Corporate action at PSG Private Equity (and its underlying investments) during the year under review included:

•  Acquired a stake of 26% in Alt-X listed Poynting, a provider of antenna related products;
•  Acquired a stake of 50% in IT Schools Innovation, a provider of e-learning solutions to schools;
•  M&S Holdings concluded its merger with BDM Holdings to form Alt-X listed CSG Holdings, a diversified outsourced services 
   group; and
•  CA Sales Holdings acquired a stake of 49% in SMC Brands, a distributor of liquor products.

THEMBEKA CAPITAL (49%)

Thembeka is a black-owned and controlled investment company. Its portfolio of R3,1bn includes investments in Capitec, Curro, 
Kaap Agri, MTN Zakhele, Pioneer Foods and PSG.

Thembeka has, under the leadership of KK Combi, grown its intrinsic value (net of CGT) by 52% per year over the past eight
years and as such remains an extraordinary BEE success story. During the year ended 28 February 2014, Thembeka’s net intrinsic 
value (after CGT) increased by 37% to R2,1bn.

Thembeka continues to support growth initiatives in its underlying investments with a view to enhancing portfolio returns.

Thembeka’s comprehensive results for the year ended 28 February 2014 are available at www.thembekacapital.co.za.

PROSPECTS

PSG operates in a number of diverse industries, the performance of which is not always correlated. Although it is difficult to 
predict the future, we remain optimistic and believe our strategy will continue to deliver superior returns for shareholders.

DIVIDENDS

Ordinary shares

PSG’s policy remains to pay up to 100% of free cash flow as an ordinary dividend, of which one third is payable as an interim 
and the balance as a final dividend at year-end. The directors have resolved to declare a gross final dividend of 90 cents 
(2013: 78 cents) per share for a total gross dividend of 133 cents (2013: 111 cents) for the year ended 28 February 2014.

The company will be utilising secondary tax on companies credits amounting to 16,1 cents per ordinary share and, as a result,
the taxable final dividend per share will amount to 73,9 cents per share. The final dividend amount, net of South African
dividend tax of 15% equating to 11.085 cents per share, is therefore 78,915 cents per share for those shareholders that are
not exempt from dividend tax. The number of ordinary shares in issue at the declaration date is 207 589 426, and the income
tax number of the company is 9950080714.

The salient dates of this dividend distribution are:
Last day to trade cum dividend                                              Friday, 9 May 2014
Trading ex dividend commences                                              Monday, 12 May 2014
Record date                                                                Friday, 16 May 2014
Date of payment                                                            Monday, 19 May 2014

Share certificates may not be dematerialised or rematerialised between Monday, 12 May 2014, and Friday, 16 May 2014, both days 
inclusive.

Preference shares

The directors of PSG Financial Services have declared a dividend of 354,67 cents per share in respect of the cumulative, 
non-redeemable, non-participating preference shares for the six months ended 28 February 2014, which was paid on 31 March 2014. 
The detailed announcement in respect hereof was disseminated on Stock Exchange News Services (“SENS”).

On behalf of the board

Jannie Mouton                         Piet Mouton                           Wynand Greeff
Chairman                              Chief Executive Officer               Financial Director

16 April 2014
Stellenbosch

The reviewed preliminary condensed financial information of PSG Group is presented below:

Condensed group income statement
for the year ended 28 February 2014
                                                                                    Reviewed        Audited
                                                                                      Feb-14         Feb-13
                                                                                          Rm             Rm

Revenue from sale of goods                                                           7 568,6        2 001,8
Cost of goods sold                                                                  (6 684,6)      (1 682,9)
Gross profit from sale of goods                                                        884,0          318,9

Income
Changes in fair value of biological assets                                              90,5           28,7
Investment income (note 6)                                                             507,0          418,3
Fair value gains and losses (note 6)                                                 1 453,6        1 023,9
Fair value adjustment to investment contract liabilities (note 6)                   (1 342,7)      (1 186,6)
Commission, insurance and other fee income                                           3 540,1        1 941,1
Other operating income and expenses                                                     99,3          830,1
                                                                                     4 347,8        3 055,5

Expenses
Insurance claims and loss adjustments, net of recoveries                              (353,4)         (60,0)
Marketing, administration and other expenses                                        (3 737,6)      (2 276,6)
                                                                                    (4 091,0)      (2 336,6)

Income from associates and joint ventures
Share of profits of associates and joint ventures                                      943,1        1 036,6
Loss on impairment of associates                                                       (24,5)        (104,2)
                                                                                       918,6          932,4

Profit before finance costs and taxation                                             2 059,4        1 970,2
Finance costs                                                                         (263,3)        (206,0)
Profit before taxation                                                               1 796,1        1 764,2
Taxation                                                                              (287,9)        (248,1)
Profit for the year                                                                  1 508,2        1 516,1

Attributable to:
  Owners of the parent                                                               1 052,0        1 139,8
  Non-controlling interests                                                            456,2          376,3
                                                                                     1 508,2        1 516,1

Earnings per share and number of shares in issue
                                                                                    Reviewed        Audited
                                                                       Change         Feb-14         Feb-13
                                                                            %          cents          cents

Earnings per share
- recurring headline                                                     13,9          446,9          392,3
- headline (note 4)                                                      14,8          551,3          480,2
- attributable/basic                                                     (8,1)         574,9          625,5
- diluted headline                                                       14,8          546,8          476,3
- diluted attributable/basic                                             (8,1)         570,2          620,5

Number of shares (million)
- in issue                                                                             207,6          208,1
- in issue (net of treasury shares)                                                    182,9          183,6
- weighted average                                                                     183,0          182,2
- diluted weighted average                                                             184,5          183,7

Condensed group statement of comprehensive income
for the year ended 28 February 2014
                                                                                    Reviewed        Audited
                                                                                      Feb-14         Feb-13
                                                                                          Rm             Rm

Profit for the year                                                                  1 508,2        1 516,1
Other comprehensive income for the year, net of taxation                               152,8           20,7
Items that may be subsequently reclassified to profit or loss
  Currency translation adjustments                                                     161,6           15,6
  Cash flow hedges                                                                     (15,9)
  Fair value gains and losses on investments and the reversal 
   thereof upon disposal                                                                (0,3)          (0,1)
  Share of other comprehensive income of associates                                     62,2            6,4
  Reversal of share of associates’ other comprehensive 
   income upon disposal                                                                (55,9)          (1,2)
Items that will not be reclassified to profit or loss
  Remeasurement of post-employment benefit obligations                                   1,1
Total comprehensive income for the year                                              1 661,0        1 536,8

Attributable to:
  Owners of the parent                                                               1 115,1        1 132,4
  Non-controlling interests                                                            545,9          404,4
                                                                                     1 661,0        1 536,8

Condensed group statement of financial position
as at 28 February 2014
                                                                                    Reviewed        Audited
                                                                                      Feb-14         Feb-13
                                                                                         Rm              Rm
Assets

Property, plant and equipment                                                        3 326,8        1 799,7
Intangible assets                                                                    2 094,5        1 666,5
Biological assets                                                                      201,4           31,3
Investment in ordinary shares of associates and joint ventures                       6 312,1        5 961,3
Investment in preference shares of/loans granted 
 to associates and joint ventures                                                      321,3          312,7
Deferred income tax assets                                                             125,9           59,5
Financial assets linked to investment contracts (note 6)                            12 692,8       10 272,4
  Cash and cash equivalents (including money market funds)                              51,3           65,1
  Other financial assets                                                            12 641,5       10 207,3
Other financial and employee benefit assets                                          1 536,0          734,0
Inventory                                                                              913,7          320,8
Trade and other receivables (note 7)                                                 3 718,8        2 243,6
Current income tax assets                                                               42,9           14,6
Cash and cash equivalents (including money market funds)                             2 098,6        2 153,2
Non-current assets held for sale (note 9)                                              182,0          287,7
Total assets                                                                        33 566,8       25 857,3

Equity

Ordinary shareholders’ equity                                                        6 855,2        5 989,7
Non-controlling interests                                                            5 591,6        4 159,8
Total equity                                                                        12 446,8       10 149,5

Liabilities
Insurance contracts                                                                    493,2          378,0
Financial liabilities under investment contracts (note 6)                           12 692,8       10 272,4
Borrowings and other financial liabilities                                           3 740,9        2 373,4
Deferred income tax liabilities                                                        331,6          243,5
Trade and other payables and employee benefit liabilities (note 7)                   3 823,2        2 434,2
Current income tax liabilities                                                          38,3            6,3
Total liabilities                                                                   21 120,0       15 707,8

Total equity and liabilities                                                        33 566,8       25 857,3

Net asset value per share (cents)                                                    3 747,6        3 261,6
Net tangible asset value per share (cents)                                           2 602,6        2 354,1

Condensed group statement of changes in equity
for the year ended 28 February 2014
                                                                                    Reviewed        Audited
                                                                                      Feb-14         Feb-13
                                                                                          Rm             Rm

Ordinary shareholders’ equity at beginning of the year                               5 989,7        4 759,9
Total comprehensive income                                                           1 115,1        1 132,4
Issue of shares                                                                                       361,0
Share buy-back                                                                         (33,1)
Share-based payment costs - employees                                                   26,2           14,2
Net movement in treasury shares                                                        (41,0)        (123,4)
Transactions with non-controlling interests                                             20,1            7,6
Dividends paid                                                                        (221,8)        (162,0)
Ordinary shareholders’ equity at end of the year                                     6 855,2        5 989,7

Non-controlling interests at beginning of the year                                   4 159,8        3 187,7
Total comprehensive income                                                             545,9          404,4
Issue of shares                                                                        737,3          551,5
Share-based payment costs - employees                                                    9,5            3,3
Acquisition of subsidiaries (note 5)                                                   366,4          202,0
Transactions with non-controlling interests                                            (33,3)         (32,2)
Dividends paid                                                                        (194,0)        (156,9)
Non-controlling interests at end of the year                                         5 591,6        4 159,8
       
Total equity                                                                        12 446,8       10 149,5

Dividend per share (cents)
- interim                                                                               43,0           33,0
- final                                                                                 90,0           78,0
                                                                                       133,0          111,0

Condensed group statement of cash flows
for the year ended 28 February 2014 
                                                                                    Reviewed        Audited
                                                                                      Feb-14         Feb-13
                                                                                          Rm             Rm

Cash generated by operations                                                         1 532,8          623,9
Cash movement in policyholder funds (note 6)                                           (13,8)         (32,1)
Finance costs and taxation paid                                                       (512,4)        (467,2)
Net cash flow from operating activities                                              1 006,6          124,6
Net cash flow from investing activities                                             (1 235,8)         (12,0)
Net cash flow from financing activities                                               (164,6)       1 183,0
Net (decrease)/increase in cash and cash equivalents                                  (393,8)       1 295,6
Exchange gains on cash and cash equivalents                                             46,7            1,5
Cash and cash equivalents at beginning of the year                                   1 927,7          630,6
Cash and cash equivalents at end of the year                                         1 580,6        1 927,7

Cash and cash equivalents consists of:
  Cash and cash equivalents linked to investment contracts                              51,3           65,1
  Cash and cash equivalents attributable to equity holders                           2 098,6        2 153,2
  Bank overdrafts attributable to equity holders (included in borrowings)             (569,3)        (290,6)
                                                                                     1 580,6        1 927,7

Notes to the condensed group financial statements

1. Basis of presentation and accounting policies

These condensed group financial statements have been prepared in accordance with the recognition and 
measurement principles of International Financial Reporting Standards (“IFRS”) as issued by the International 
Accounting Standards Board, including IAS 34 Interim Financial Reporting; the SAICA Financial Reporting Guides, 
as issued by the Accounting Practices Committee; the Financial Reporting Pronouncements, as issued by the Financial 
Reporting Standards Council; the requirements of the South African Companies Act, 71 of 2008, as amended; and the 
Listings Requirements of the JSE.

The accounting policies applied in the preparation of these condensed group financial statements are consistent 
in all material respects with those used in the prior financial year, apart from the following new accounting standards 
and amendments to IFRSs which were relevant to the group’s operations from 1 March 2013:

-   IFRS 10 Consolidated Financial Statements, IFRS 11 Joint Arrangements and amendments to IAS 28 Investments 
    in Associates
    The group has adopted aforementioned suite of IFRSs and amendments which deal with the accounting treatment for 
    the group’s interests in its investees. The group has reviewed its accounting policies and concluded that the 
    adoption of same did not result in any material changes to the group’s accounting for its investees.

-   IFRS 13 Fair Value Measurement
    The group has adopted the new standard on how to measure fair value and enhance fair value disclosures. The 
    adoption did not result in any material impact on the financial statements, apart from additional disclosures 
    (note 10).

-   Amendments to IAS 19 Employee Benefits
    The amendments became relevant to the group following its acquisition of a controlling interest in Capespan 
    Group Ltd (“Capespan”) (note 5), which operates defined benefit plans. Capespan previously elected to follow a 
    policy of recognising remeasurements to employee benefit assets and liabilities in other comprehensive income, 
    which has now become mandatory.

-   Amendments to IAS 34 Interim Financial Reporting
    The amendments relate to the introduction of IFRS 13 Fair Value Measurement and changes to IFRS 7 Financial 
    Instruments: Disclosures. The group has complied with these additional disclosure requirements.

The group also adopted the various other revisions to IFRS which were effective for its financial year ended 
28 February 2014. These revisions have not resulted in material changes to the group’s reported results and disclosures 
in these condensed group financial statements.

Enhanced disclosures, as required by IFRS 12 Disclosures of Interests in Other Entities, will be provided in the 
annual financial statements for the year ended 28 February 2014.

2. Preparation

These preliminary condensed group financial statements were compiled under the supervision of the group financial
director, Mr WL Greeff, CA (SA), and were reviewed by PSG Group’s external auditor, PricewaterhouseCoopers Inc.
A copy of their unmodified review opinion is available from PSG Group’s registered office. Any reference to future
financial performance included in this announcement, has not been reviewed or reported on by the company’s auditor.

The auditor’s report does not necessarily report on all the information contained in this announcement. Users are
therefore advised that in order to get a full understanding of the nature of the auditor’s engagement, they should
obtain a copy of the auditor’s report together with the accompanying financial information from the company’s
registered office.

3. PSG Financial Services

PSG Financial Services is a wholly-owned subsidiary of PSG Group, except for the 17 415 770 (2013: 13 419 479) 
perpetual preference shares which are listed on the JSE. These preference shares are included in non-controlling 
interests in the statement of financial position. No separate financial statements are presented in this announcement 
for PSG Financial Services as it is the only asset of PSG Group.

                                                                                    Reviewed        Audited
                                                                                      Feb-14         Feb-13
                                                                                          Rm             Rm

4. Reconciliation to headline earnings

Profit for the year attributable to owners of the parent                             1 052,0        1 139,8
Non-headline items                                                                     (43,2)        (264,8)
Gross amounts
  Impairment of investments in associates                                               24,5          104,1
  Net profit on sale/dilution of investments in associates                             (24,4)        (728,6)
  Fair value gain on step-up from associate to subsidiary                              (79,5)         (21,2)
  Net loss on sale/impairment of intangible assets (including goodwill)                  9,2          167,9
  Non-headline items of associates                                                     (16,7)         (23,2)
  Other                                                                                  3,6            6,9
Non-controlling interests                                                               32,9          106,6
Taxation                                                                                 7,2          122,7
Headline earnings                                                                    1 008,8          875,0

5. Business combinations

The group’s most significant business combinations entered into during the year under review included:

Capespan Group Ltd (“Capespan”)

Effective April 2013, the group, through Zeder, acquired a further 25,3% shareholding in Capespan and thereby
increased its interest to 71,1%. Subsequently, the group further increased its interest to 72,1% in Capespan.
Capespan is a global fruit procurement company and South Africa’s largest fruit exporter. Remeasurement to fair 
value of the associate interest previously held resulted in a non-headline gain of R40,7m being recognised in “fair 
value gains and losses” in the income statement. Non-controlling interest was recognised at its fair value based on 
Capespan’s over-the-counter traded share price.

Klein Karoo Seed Marketing (Pty) Ltd (“Klein Karoo”)

Effective October 2013, the group, through Zeder, acquired the remaining 51% shareholding in Klein Karoo not already
held. Klein Karoo develops and distributes vegetable, pasture and agronomic seed in mainly Africa, the Middle East 
and Asia. The remeasurement of the previously held associate interest resulted in a non-headline gain of R1,1m being
recognised in “fair value gains and losses” in the income statement. Non-controlling interests in a subsidiary of 
Klein Karoo were valued at its fair value.

Precrete Holdings (Pty) Ltd (“Precrete”)

Effective August 2013, the group, through PSG Private Equity, acquired a further 7,2% shareholding in Precrete and 
thereby increased its interest to 55,2%. At year-end, the group’s effective interest in Precrete was 52,8%. Precrete
is involved in providing mine safety and support services. The previously held associate interest approximated fair 
value and therefore no remeasurement gain or loss arose upon gaining control. Non-controlling interests were recognised 
at its proportionate share of net assets.

Embury Institute for Teacher Education (Pty) Ltd (“Embury”)

Effective April 2013, the group, through Curro, acquired the entire issued shareholding in Embury, a Durban-based
teachers training college.

Northern Academy

Effective April 2013, the group, through Curro, acquired the entire business operations and properties of Northern
Academy, a private education campus in Polokwane.

PSG Optimal Income Fund

During the year under review, the group, through PSG Konsult, increased its interest in the PSG Optimal Income Fund,
resulting in the consolidation of same. At year-end, the group’s interest in this fund amounted to 34,1%.

The amounts of identifiable net assets acquired, goodwill and non-controlling interests recognised from aforementioned 
business combinations can be summarised as follows:

                                                                                                            Sub-total
                                                                                                              carried
                                                  Capespan     Klein Karoo      Precrete         Embury       forward
                                                        Rm              Rm            Rm             Rm            Rm

Identifiable net assets acquired                     929,5           196,2         152,7           20,9       1 299,3
Goodwill recognised                                                   69,1          77,0           37,7         183,8
Non-controlling interests recognised                (268,6)          (34,2)        (63,6)                      (366,4)
                                                     660,9           231,1         166,1           58,6       1 116,7
Derecognition of previously held 
 associate interest or unit-linked
 investment at fair value                           (403,0)         (101,0)       (146,4)                      (650,4)
Cash consideration                                   257,9           130,1          19,7           58,6         466,3

                                                                                     PSG 
                                                 Sub-total                       Optimal
                                                   brought        Northern        Income 
                                                   forward         Academy          Fund          Other         Total
                                                        Rm              Rm            Rm             Rm            Rm

Identifiable net assets acquired                   1 299,3            64,7          97,0           26,1       1 487,1
Goodwill recognised                                  183,8            85,2                                      269,0
Non-controlling interests recognised                (366,4)                                                    (366,4)
                                                   1 116,7           149,9          97,0           26,1       1 389,7
Derecognition of previously held 
 associate interest or unit-linked
 investment at fair value                           (650,4)                        (97,0)                      (747,4)
Cash consideration                                   466,3           149,9             -           26,1         642,3

Goodwill recognised from these business combinations can be attributed to the employee corps, expected synergies, economies 
of scale and the businesses’ growth potential. Transaction costs relating to aforementioned business combinations were 
insignificant and expensed in the income statement.

6. Linked investment contracts

These represent PSG Life Ltd clients’ assets held under investment contracts, which are linked to a corresponding liability.
The impact on the income statement from the returns on investment contract policy holder assets and liabilities, as well as
the investment income earned by the ordinary shareholders of the group, were as follows:

                                                                               Investment
                                                                                 contract
                                                                                   policy        Equity
                                                                                  holders       holders         Total
28 February 2014 - Reviewed                                                            Rm            Rm            Rm

Investment income                                                                   263,6         243,4         507,0
Fair value gains and losses                                                       1 087,7         365,9       1 453,6
Fair value adjustment to investment contract liabilities                         (1 342,7)                   (1 342,7)
                                                                                      8,6         609,3         617,9

28 February 2013 - Audited

Investment income                                                                   272,0         146,3         418,3
Fair value gains and losses                                                         937,1          86,8       1 023,9
Fair value adjustment to investment contract liabilities                         (1 186,6)                   (1 186,6)
                                                                                     22,5         233,1         255,6

7. Trade and other receivables and payables

Included under trade and other receivables are PSG Online broker- and clearing accounts of which R1,9bn (2013: R1,6bn)
represents amounts owing by the JSE for trades conducted during the last few days before year-end. These balances 
fluctuate on a daily basis depending on the activity in the markets.

The control account for the settlement of these transactions is included under trade and other payables, with the 
settlement to clients taking place within three days after the transaction date.

8. Corporate actions

Apart from the transactions set out in note 5, the group’s most significant corporate actions included the following:

 -  Repurchase of 492 471 PSG Group ordinary shares for R33,1m cash at R67,19 per share.
 -  Issue of 3 996 291 PSG Financial Services preference shares for cash proceeds of R300m at an effective dividend 
    yield of 9,44% and partial utilisation thereof to redeem promissory notes upon maturity of R269,8m.
 -  Curro conducted a rights offer during May 2013, which was partially underwritten by the group. The group followed 
    its rights and the additional investment amounted to R350,6m.
 -  Effective June 2013, the group, through PSG Konsult, increased its shareholding in Western Group Holdings Ltd 
    (“Western”), being a short-term insurer, from 75% to 90%. Following approval from the Financial Services Board 
    during September 2013, the group acquired the remaining 10% minority shareholding in Western and then subsequently 
    sold 40% of its shareholding to Santam.

9. Non-current assets held for sale

Non-current assets held for sale consists mainly of JSE-listed equity securities to the amount of R177m (2013: 
R287,7m), held by the group, through Zeder, in Capevin Holdings Ltd. These equity securities are expected to be 
realised through sale in the coming months.

10. Financial instruments

10.1 Financial risk factors

The group’s activities expose it to a variety of financial risks: market risk (including currency risk, cash flow and
fair value interest rate risk and price risk), credit risk and liquidity risk.

These condensed group financial statements do not include all financial risk management information and disclosures 
set out in the annual financial statements, and therefore they should be read in conjunction with the group’s annual 
financial statements for the year ended 28 February 2014. Risk management continues to be carried out by each major 
entity within the group under policies approved by the respective boards of directors.

10.2 Fair value estimation

The group, through PSG Life Ltd, issues linked investment contracts (note 6) where the value of the policy benefits
(i.e. liability) is directly linked to the fair value of the supporting assets, and as such does not expose 
the group to the market risk relating to fair value movements.

The information below analyses financial assets and liabilities, which are carried at fair value, by level of hierarchy 
as required by IFRS 13. The different levels in the hierarchy are defined below:

Level 1

The fair value of financial instruments traded in active markets is based on quoted market prices at the reporting 
date. A market is regarded as active if quoted prices are readily and regularly available from an exchange, dealer,
broker, industry group, pricing service, or regulatory agency, and those prices represent actual and regularly occurring 
market transactions on an arm’s length basis. The quoted market price used for financial assets held by the group is
the current bid price.

Level 2

Financial instruments that trade in markets that are not considered to be active but are valued (using valuation 
techniques) based on quoted market prices, dealer quotations or alternative pricing sources supported by observable
inputs are classified within level 2. These include over-the-counter traded derivatives. As level 2 investments include 
positions that are not traded in active markets and/or are subject to transfer restrictions, valuations may be adjusted 
to reflect illiquidity and/or non-transferability, which are generally based on available market information. If all 
significant inputs in determining an instrument’s fair value are observable, the instrument is included in level 2.

Level 3

If one or more of the significant inputs is not based on observable market data, the instrument is included in 
level 3. Investments classified within level 3 have significant unobservable inputs, as they trade infrequently.

The fair value of financial assets and liabilities carried at amortised cost approximates their fair value, while 
those measured at fair value in the statement of financial position can be summarised as follows:

                                                                 Level 1          Level 2       Level 3         Total
28 February 2014 - Reviewed                                           Rm               Rm            Rm            Rm

Assets
  Derivative financial assets                                        1,0             29,1                        30,1
  Equity securities                                                767,8              1,0          42,6         811,4
  Debt securities                                                   32,9            804,8         237,3       1 075,0
  Unit-linked investments                                                         8 058,4       2 250,5      10 308,9
  Investment in investment contracts                                                260,4           1,4         261,8
  Non-current assets held for sale                                 177,0                                        177,0
  Closing carrying value                                           978,7          9 153,7       2 531,8      12 664,2

Liabilities
  Derivative financial liabilities                                  15,2             38,6          45,7          99,5
  Investment contracts                                                            9 056,9       2 487,8      11 544,7
  Trade and other payables                                                                         10,6          10,6
  Third party liabilities arising on 
   consolidation of mutual funds                                                    372,2                       372,2
  Closing carrying value                                            15,2          9 467,7       2 544,1      12 027,0

                                                                 Level 1          Level 2       Level 3         Total
28 February 2013 - Audited                                            Rm               Rm            Rm            Rm

Assets
  Derivative financial assets                                                        16,0                        16,0
  Equity securities                                              1 015,0             97,5           0,8       1 113,3
  Debt securities                                                                   338,5         250,1         588,6
  Unit-linked investments                                                         4 832,6       1 958,1       6 790,7
  Investment in investment contracts                                                264,8          61,7         326,5
  Non-current assets held for sale                                 287,7                                        287,7
  Closing carrying value                                         1 302,7          5 549,4       2 270,7       9 122,8

Liabilities
  Derivative financial liabilities                                                   94,4          45,7         140,1
  Investment contracts                                                            6 152,5       2 266,5       8 419,0
  Trade and other payables                                                                          6,3           6,3
  Third party liabilities arising on
   consolidation of mutual funds                                                     25,1                        25,1
  Closing carrying value                                               -          6 272,0       2 318,5       8 590,5

The following table presents changes in level 3 financial instruments during the respective years:

                                                                        Feb-14                        Feb-13
                                                                  Assets      Liabilities        Assets   Liabilities
                                                                      Rm               Rm            Rm            Rm

Opening balance                                                  2 270,7          2 318,5       1 983,9       2 048,3
Additions                                                        1 602,0          1 562,9       1 028,0         702,4
Disposals                                                       (1 506,2)        (1 504,1)       (969,8)       (707,8)
Subsidiaries sold                                                                                  (3,7)
Fair value adjustments                                             165,3            166,6         232,3         230,6
Other movements                                                                       0,2                        45,0
                                                                 2 531,8          2 544,1       2 270,7       2 318,5

Derivative financial assets, equity securities, debt securities and unit-linked investments are all included in 
“other financial assets” in the statement of financial position, while derivative financial liabilities and third 
party liabilities arising on consolidation of mutual funds are included in “other financial liabilities”.

There have been no significant transfers between level 1, 2 or 3 during the year under review, nor were there any 
significant changes to the valuation techniques and inputs used to determine fair values. Valuation techniques and 
main inputs used to determine fair value for financial instruments classified as level 2 can be summarised as follows:

Instrument                            Valuation technique                                    Main inputs

Derivative financial assets and       Exit price on recognised over-the-counter              Not applicable
liabilities                           platforms
Debt securities                       Valuation model that uses the market inputs            Bond interest rate curves
                                      (yield of benchmark bonds)                             Issuer credit ratings
                                                                                             Liquidity spreads
Unit-linked investments               Quoted put (exit) price provided by the fund           Not applicable - prices 
                                      manager                                                available publicly
Investment in investment              Prices are obtained from the insurer of the            Not applicable - prices 
contracts                             particular investment contract                         provided by registered
                                                                                             long-term insurers
Investment contracts                  Current unit price of underlying unitised              Not applicable
                                      financial asset that is linked to the liability,
                                      multiplied by the number of units held
Third party liabilities arising on    Quoted put (exit) price provided by the fund           Not applicable - prices
consolidation of mutual funds         manager                                                available publicly

11. Capital commitments and contingencies

Zeder has previously announced the acquisition of Mpongwe Milling in its SENS announcement dated 13 November 2013, 
which became effective after the reporting date and is currently being implemented.

Curro announced in its recently released financial results that during the year ahead it intends to develop 10 new 
schools and embark on expansion projects at approximately seven existing campuses across the group.

Capitec has reported receiving a notice from the National Credit Regulator alleging contraventions of the National 
Credit Act. It furthermore reported that it had taken legal advice and believed the matter would be resolved 
satisfactorily through due process.The matter was heard by the National Consumer Tribunal on 13 March 2014 and judgement 
was reserved. Due to uncertainties that currently exist, Capitec is unable to estimate the financial effect of any 
possible outcome.

12. Segment report

The group’s classification into seven reportable segments, namely: Capitec, Curro, PSG Konsult, PSG Private Equity,
Thembeka Capital, Zeder and PSG Corporate, remains unchanged. These segments represent the major investments of the 
group. The services offered by PSG Konsult consist of financial advice, stock broking, fund management and insurance, while
Curro offers private education services. The other segments offer financing, banking, investing and corporate finance services.
All segments operate predominantly in the Republic of South Africa, however, Zeder has further expanded its offshore operations
through the acquisition of Capespan and Klein Karoo (note 5).

Intersegment income represents income derived from other segments within the group which is recorded at the fair value of the
consideration received or receivable for services rendered in the ordinary course of the group’s activities. Intersegment 
income mainly comprises intergroup management fees charged in terms of the respective management agreements.

Headline earnings comprise recurring and non-recurring headline earnings. Recurring headline earnings are calculated on a 
proportional basis, and include the proportional headline earnings of underlying investments, excluding marked-to-market 
adjustments and one-off items. The result is that investments in which the group holds less than 20% and which are generally 
not equity accountable in terms of accounting standards, are equity accounted for the purpose of calculating the consolidated 
recurring headline earnings. Non-recurring headline earnings include one-off gains and losses and marked-to-market fluctuations, 
as well as the resulting taxation charge on these items. Sum-of-the-parts (“SOTP”) is a key valuation tool used to measure PSG’s
performance. In determining SOTP, listed assets and liabilities are valued using quoted market prices, whereas unlisted assets 
and liabilities are valued using appropriate valuation methods. These values will not necessarily correspond with the values per 
the statement of financial position since the latter are measured using the relevant accounting standards which include 
historical cost and the equity method of accounting.

The chief operating decision-maker (the PSG Group Executive Committee) evaluates the following information to assess the
segments’ performance:

                                                                          Recurring
                                                                Inter-     headline          Non-
                                                               segment     earnings     recurring
                                                     Income     income     (segment      headline      Headline
                                                         **         **       profit)     earnings      earnings         SOTP^
Year ended 28 February 2014 - Reviewed                   Rm         Rm           Rm            Rm            Rm            Rm

Capitec*                                                                      570,7                       570,7       5 989,1
Curro                                                 662,9                    20,6                        20,6       4 659,7
PSG Konsult                                         2 488,8                   162,7          (4,3)        158,4       4 003,8
PSG Private Equity                                  2 189,1                    51,4           5,7          57,1         948,7
Thembeka Capital*                                                              23,2         100,2         123,4       1 242,8
Zeder                                               6 374,3                   124,5         (16,9)        107,6       1 698,1
PSG Corporate (including PSG Capital)                 301,1     (123,5)        48,4          51,9         100,3       1 370,5
Reconciling items
  Funding                                              42,2      (18,5)      (181,2)         54,2        (127,0)     (2 008,3)
  Other                                                                        (2,3)                       (2,3)        135,0
Total                                              12 058,4     (142,0)       818,0         190,8       1 008,8      18 039,4
Non-headline items                                                                                         43,2
Earnings attributable to non-controlling interests                                                        456,2
Taxation                                                                                                  287,9
Profit before taxation                                                                                  1 796,1

                                                                          Recurring
                                                                Inter-     headline          Non-
                                                               segment     earnings     recurring
                                                     Income     income     (segment      headline      Headline
                                                         **         **       profit)     earnings      earnings         SOTP^
Year ended 28 February 2013 - Audited                    Rm         Rm           Rm            Rm            Rm            Rm

Capitec*                                              410,1                   499,9                       499,9       6 127,6
Curro                                                 367,3                     8,1                         8,1       2 606,6
PSG Konsult                                         1 673,0                   118,8          (0,1)        118,7       2 236,8
PSG Private Equity                                  1 690,9                    75,0          (9,2)         65,8         680,7
Thembeka Capital*                                                              28,0         140,0         168,0         898,8
Zeder                                                 755,5                   106,6         (23,2)         83,4       1 411,6
PSG Corporate (including PSG Capital)++               190,7      (61,0)        48,3          85,9         134,2       1 855,2
Reconciling items
  Funding++                                            39,0       (8,2)      (168,2)        (33,3)       (201,5)     (2 008,2)
  Other                                                                        (1,6)                       (1,6)         34,4
Total                                               5 126,5      (69,2)       714,9         160,1         875,0      13 843,5
Non-headline items                                                                                        264,8
Earnings attributable to non-controlling interests                                                        376,3
Taxation                                                                                                  248,1
Profit before taxation                                                                                  1 764,2


                                                                                                       Reviewed       Audited
                                                                                                         Feb-14        Feb-13
Reconciliation of segment revenue to IFRS revenue:                                                           Rm            Rm

Segment revenue as stated above
  Income                                                                                               12 058,4       5 126,5
  Inter-segment income                                                                                   (142,0)        (69,2)
Less:
  Changes in fair value of biological assets                                                              (90,5)        (28,7)
  Fair value gains and losses                                                                          (1 453,6)     (1 023,9)
  Fair value adjustment to investment contract liabilities                                              1 342,7       1 186,6
  Other operating income and expenses                                                                     (99,3)       (830,1)
IFRS revenue                                                                                           11 615,7       4 361,2

Non-recurring headline earnings comprised the following:

Non-recurring items from investments                                                                       84,7         107,5
Net fair value gains on unit trust and share investments                                                    9,5          72,0
Other+                                                                                                     96,7         (19,4)
                                                                                                          190,9         160,1

 * Equity method of accounting applied.
** The total of “income” and “intersegment income” comprises the total of “revenue from sale of goods” and “income” per the 
   income statement.
 ^ SOTP is a key valuation tool used to measure the group’s performance, but does not necessarily correspond to net asset value.
 + Current year consists mainly of marked-to-market gains on the group’s interest rate hedge.
++ Non-recurring headline losses of R29,1m pertaining to the group’s interest rate hedge has been reclassified from PSG 
   Corporate to Funding.

DIRECTORS:
JF Mouton (Chairman)+, PE Burton^, ZL Combi^, J de V du Toit^, MM du Toit^, FJ Gouws+, WL Greeff (FD)*,
JA Holtzhausen*, MJ Jooste^ (Alt: AB la Grange), JJ Mouton+, PJ Mouton (CEO)*, CA Otto^, W Theron+ 
* Executive  + Non-executive  ^ Independent non-executive

SECRETARY AND REGISTERED OFFICE:
PSG Corporate Services (Pty) Ltd, 1st Floor, Ou Kollege, 35 Kerk Street, Stellenbosch, 7600; PO Box 7403,
Stellenbosch, 7599

TRANSFER SECRETARY:
Computershare Investor Services (Pty) Ltd, 70 Marshall Street, Johannesburg, 2001; PO Box 61051, Marshalltown, 2107

SPONSOR:
PSG Capital

AUDITOR:
PricewaterhouseCoopers Inc.
Date: 16/04/2014 02:16:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story